Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer

Journal of Molecular Diagnostics

Volumn 15, Issue 4, 2013, Pages 498-507

  Oh, Taejeong ^a   Kim, Nayoung ^a   Moon, Youngho ^a   Kim, Myung Soon ^a   Hoehn, Benjamin D ^a   Park, Chan Hee ^b   Kim, Tae Soo ^b   Kim, Nam Kyu ^b   Chung, Hyun Cheol ^b   An, Sungwhan ^a  

^a Genomictree Inc   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA;

ADULT; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DATA ANALYSIS; DNA METHYLATION; DNA MICROARRAY; EARLY DIAGNOSIS; FEMALE; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; SDC2 GENE; SENSITIVITY AND SPECIFICITY; TUMOR GENE; VALIDATION STUDY;

ADULT; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; SYNDECAN-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84879289642     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.03.004     Document Type: Article

References (37)

1. Y.X. Luo, D.K. Chen, S.X. Song, L. Wang, and J.P. Wang Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis Int J Clin Pract 65 2011 1313 1320
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. R.H. Dashwood Early detection and prevention of colorectal cancer (review) Oncol Rep 6 1999 277 281
4. B. Levin, D.A. Lieberman, B. McFarland, R.A. Smith, D. Brooks, K.S. Andrews, C. Dash, F.M. Giardiello, S. Glick, T.R. Levin, P. Pickhardt, D.K. Rex, A. Thorson, S.J. Winawer American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin 58 2008 130 160
5. D.K. Rex, D.A. Johnson, J.C. Anderson, P.S. Schoenfeld, C.A. Burke, J.M. Inadomi American College of Gastroenterology American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] [Erratum appeared in Am J Gastroenterol 2009, 104:1613] Am J Gastroenterol 104 2009 739 750
6. W. Schmiegel, A. Reinacher-Schick, D. Arnold, U. Graeven, V. Heinemann, R. Porschen, J. Riemann, C. Rödel, R. Sauer, M. Wieser, W. Schmitt, H.J. Schmoll, T. Seufferlein, I. Kopp, and C. Pox S3-Leitlinie "Kolorektales Karzinom" Update S3-guideline "colorectal cancer" 2008 German Z Gastroenterol 46 2008 799 840
7. G.C. Harewood, M.J. Wiersema, and L.J. Mearalton 3rd A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy Am J Gastroenterol 97 2002 3186 3194
8. M. Ziegler, B. Schubring-Giese, M. Bühner, and F.T. Kolligs Attitude to secondary prevention and concerns about colonoscopy are independent predictors of acceptance of screening colonoscopy Digestion 81 2010 120 126
9. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
10. P.W. Laird The power and the promise of DNA methylation markers Nat Rev Cancer 3 2003 253 266
11. Widschwendter M, Menon U: Circulating methylated DNA: a new generation of tumor markers. Clin Cancer Res 2006, 12:7205-7208
12. H. Fiegl, S. Millinger, E. Mueller-Holzner, C. Marth, C. Ensinger, A. Berger, H. Klocker, G. Goebel, and M. Widschwendter Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients Cancer Res 65 2005 1141 1145
13. R.E. Board, L. Knight, A. Greystoke, F.H. Blackhall, A. Hughes, C. Dive, and M. Ranson DNA methylation in circulating tumor DNA as a biomarker for cancer Biomark Insights 2 2008 307 319
14. Y. Kondo, and J.P. Issa Epigenetic changes in colorectal cancer Cancer Metastasis Rev 23 2004 29 39
15. A. Widschwendter, H.M. Müller, H. Fiegl, L. Ivarsson, A. Wiedemair, E. Müller-Holzner, G. Goebel, C. Marth, and M. Widschwendter DNA methylation in serum and tumors of cervical cancer patients Clin Cancer Res 10 2004 565 571
16. J.D. Warren, W. Xiong, A.M. Bunker, C.P. Vaughn, L.V. Furtado, W.L. Roberts, J.C. Fang, W.S. Samowitz, and K.A. Heichman Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer BMC Med 9 2011 133
17. M.P. Ebert, F. Model, S. Mooney, K. Hale, J. Lograsso, L. Tonnes-Priddy, J. Hoffman, A. Csepregi, C. Röcken, B. Molnar, H.U. Schulz, P. Malfertheiner, and C. Lofton-Day Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas Gastroenterology 131 2006 1418 1430
18. T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, J. Distler, K.V. Steiger, R. Grützmann, C. Pilarsky, J.K. Habermann, P.R. Fleshner, B.M. Oubre, R. Day, A.Z. Sledziewski, and C. Lofton-Day Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer Clin Chem 55 2009 1337 1346
19. A. Shirahata, K. Sakuraba, T. Goto, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, and K. Hibi Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients Anticancer Res 30 2010 5015 5018
20. C.P. Lange, M. Campan, T. Hinoue, R.F. Schmitz, A.E. van der Meulen-de Jong, H. Slingerland, P.J. Kok, C.M. van Dijk, D.J. Weisenberger, H. Shen, R.A. Tollenaar, and P.W. Laird Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer PLoS One 7 2012 e50266
21. Y.H. Moon, T.J. Oh, N.Y. Kim, M.S. Kim, and S.W. An Methylated DNA isolation Am Biotechnol Lab 27 2009 23 25
22. E. Dejeux, H. EI Abdalaoui, I.G. Gut, and J. Tost Identification and quantification of differentially methylated loci by the pyrosequencing technology Methods Mol Biol 507 2009 189 205
23. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, C. Blake, D. Shibata, P.V. Danenberg, and P.W. Laird MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Res 28 2000 E32
24. C.A. Eads, R.V. Lord, K. Wickramasinghe, T.I. Long, S.K. Kurumboor, L. Bernstein, J.H. Peters, S.R. DeMeester, T.R. DeMeester, K.A. Skinner, and P.W. Laird Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 61 2001 3410 3418
25. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101 1108
26. M. Tänzer, B. Balluff, J. Distler, K. Hale, A. Leodolter, C. Röcken, B. Molnar, R. Schmid, C. Lofton-Day, T. Schuster, and M.P. Ebert Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions PLoS One 5 2010 e9061
27. A.C. Rapraeger Sydecan-regulated receptor signaling J Cell Biol 149 2000 995 998
28. H. Ryu, J. Lee, S. Yang, H. Park, S. Choi, K.C. Jung, S.T. Lee, J.K. Seong, I.O. Han, and E.S. Oh Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells J Biol Chem 284 2009 35692 35701
29. Y. Choi, H. Kim, H. Chung, J.S. Hwang, J.A. Shin, I.O. Han, and E.S. Oh Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation Biochem Biophys Res Commun 391 2010 921 925
30. D. Hrabar, G. Aralica, M. Gomercic, N. Ljubicic, B. Kruslin, and D. Tomas Epithelial and stromal expression of syndecan-2 in pancreatic carcinoma Anticancer Res 30 2010 2149 2153
31. S.A. Leon, A. Green, M.J. Yaros, and B. Shapiro Radioimmunoassay for nanogram quantities of DNA J Immunol Methods 9 1975 157 164
32. M. Esteller, M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S.B. Baylin, and J.G. Herman Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients [Erratum appeared in Cancer Res 1999, 59:3853] Cancer Res 59 1999 67 70
33. M. Sanchez-Cespedes, M. Esteller, L. Wu, H. Nawroz-Danish, G.H. Yoo, W.M. Koch, J. Jen, J.G. Herman, and D. Sidransky Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 2000 892 895
34. D.A. Lieberman Clinical practice. Screening for colorectal cancer N Engl J Med 361 2009 1179 1187
35. A. Herbst, K. Rahmig, P. Stieber, A. Philipp, A. Jung, A. Ofner, A. Crispin, J. Neumann, R. Lamerz, and F.T. Kolligs Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer Am J Gastroenterol 106 2011 1110 1118
36. K. Hibi, T. Goto, A. Shirahata, M. Saito, G. Kigawa, H. Nemoto, and Y. Sanada Detection of TFPI2 methylation in the serum of colorectal cancer patients Cancer Lett 311 2011 96 100
37. Z.H. Huang, L.H. Li, F. Yang, and J.F. Wang Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions World J Gastroenterol 13 2007 950 954